Venture Capital For MedTech “Somewhat Resilient,” With 18% Drop In ’08
This article was originally published in The Gray Sheet
Executive Summary
The U.S. medical technology industry's access to private venture capital remained relatively strong in 2008, while its ability to raise funds through debt and public stock offerings took a beating from the global financial crisis, according to a recent 1report by consulting firm Ernst & Young